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Summary
 
T helper cell (Th) 1, but not Th2, effectors undergo rapid Fas/Fas ligand (FasL)-mediated, ac-
tivation-induced cell death upon restimulation with antigen. Unequal apoptosis is also ob-
served without restimulation, after a longer lag period. Both effectors undergo delayed apopto-
sis induced by a non–Fas-mediated pathway. When Th1 and Th2 effectors are co-cultured,
Th2 effectors survive preferentially, suggesting the responsible factor(s) is intrinsic to each pop-
ulation. Both Th1 and Th2 effectors express Fas and FasL, but only Th2 effectors express high
levels of FAP-1, a Fas-associated phosphatase that may act to inhibit Fas signaling. The rapid
death of Th1 effectors leading to selective Th2 survival provides a novel mechanism for differ-
ential regulation of the two subsets.
 
A
 
ctivation-induced cell death (AICD)
 
1
 
 in CD4
 
1
 
 Th has
been widely studied. It is the mechanism of peripheral
deletion of CD4
 
1
 
 cells and is implicated in the loss of effec-
tors during infectious diseases, especially those caused by vi-
ruses (1, 2). The antigen-induced deletion of Th is often
accompanied by an imbalance in Th1 and Th2. HIV infec-
tion leads to a progressive loss of Th1 by Fas/Fas ligand
(FasL)–mediated AICD, whereas normal levels of Th2 cy-
tokine production after stimulation are seen both early and
very late in AIDS (3). Some models of acquired tolerance
are also associated with selective loss of Th1 and persistence
of Th2 (4, 5). The mechanisms underlying these imbal-
ances in Th subsets remain unclear. Th2 predominance is
also seen at high antigen doses in response to some model
antigens and to some infectious antigens (6, 7). Th1 lines
have been reported to be more susceptible to AICD than
Th2 lines, but the susceptibility of T cell subsets obtained
without prolonged culture is unclear (8).
During a primary response, resting naive cells are se-
lected by a specific antigen to proliferate and differentiate
into large, activated effector cells with the capacity to rap-
idly produce high titers of cytokines after restimulation (9).
Effectors behave differently from naive cells. They are more
easily triggered (10), they proliferate directly to cytokines,
and they have been reported to be highly susceptible to
AICD (11–13).
The pattern of cytokines produced by an effector popu-
lation upon reencounter with antigen will in large part de-
termine its function. The two most polarized patterns of
cytokine production, Th1 (characterized by production of
IL-2, IFN-
 
g
 
, TNF-
 
a
 
, and TNF-
 
b
 
) and Th2 (production
of IL-4, -5, -6, -10, and -13) were originally reported in
long-term clones of CD4 T cells (14). Activated or mem-
ory T cell populations from animals usually secrete a
broader variety of cytokines (9). However, dramatic polar-
ization can be achieved by adding IFN-
 
g
 
 or IL-12 on one
hand, or IL-4 on the other, to naive CD4 T cells respond-
ing to antigen in vitro, resulting in the respective genera-
tion of Th1 and Th2 effectors in 4–5 d of culture (15–17).
The polarization of short-term lines is often very stable;
polarized Th1 and Th2 effectors generated from the naive
CD4 T cells derived from TCR transgenic (Tg) mice upon
transfer to adoptive hosts, develop into resting memory
cells that retain their polarization for up to a year without
exposure to antigen (18).
 
1
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 AICD, activation-induced cell death;
CFSE, 5- (and 6-) carboxyfluorescein diacetate succinimidyl ester; FasL,
Fas ligand; ICAM, intracellular adhesion molecule; FAP-1, Fas-associated
phosphatase 1; FL, fluorescein; mRNA, messenger RNA; PCCF, pigeon
cytochrome c fragment 88-104; RPA, RNase protection assay; TdT, ter-
minal deoxynucleotidyl transferase; Tg, transgenic.
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Th1 and Th2 lines differ in their activation requirements
(19, 20), in their abilities to be anergized (19, 20), and in
their susceptibility to AICD (8). However, the reported dis-
tinctions in AICD have been seen predominantly in cell
lines and not in populations derived from short-term cul-
tures (8, 21, 22). Death of activated T cells is often medi-
ated by interactions between Fas and FasL (8, 22–25), but
an alternate pathway involving interaction of TNF-
 
a
 
 with
TNFR has also been described (26, 27). We previously re-
ported that unstimulated Th2 effectors persist up to a week
in culture in the absence of additional stimulation, and that
even after restimulation with antigen, they did not undergo
substantial levels of apoptosis until 4–5 d (13). This time
course for AICD is much longer than those usually re-
ported for bulk activated T cells, T cell lines (21, 22), or
T cell hybridomas (23, 24).
To evaluate whether there are physiologically relevant
functional differences in AICD between Th1- and Th2-
polarized T cells and to investigate the bases of such dis-
tinctions, we have compared well-polarized effectors gen-
erated by short-term culture from highly purified naive CD4
populations derived from TCR Tg mice. These populations
are analogous to effectors generated in vivo in response to
antigen (28) and they do not have the disadvantage of hav-
ing been selected in vitro by multiple restimulation, which
is likely to select for cells that are relatively resistant to cell
death. Our results indicate that Th1, but not Th2, effectors
undergo a rapid Fas/FasL-mediated AICD upon reactiva-
tion with antigen. This difference between Th1 and Th2
effectors may be responsible for the predominance of Th2
effectors in a number of disease states.
 
Material and Methods
 
Mice.
 
H-2
 
b/k
 
 or H-2
 
k/k
 
 V
 
b
 
3/V
 
a
 
11 and TCR Tg mice (15)
were used at 3–6 mo of age and bred in the animal facilities at
University of California, San Diego (La Jolla, CA). C3H.HeJ (C3H),
C3H.MRL-Fas
 
lpr
 
 (
 
lpr
 
), and sex- and age-matched C3H/HeJ-
FasL
 
gld
 
 (
 
gld
 
) mice were used at 6–12 wk (purchased from Jackson
Labs., Bar Harbor, ME).
 
Reagents.
 
Medium for all in vitro cultures was complete
RPMI supplemented with penicillin (200 
 
m
 
g/liter), streptomycin
(200 
 
m
 
g/liter), and glutamine (4 
 
m
 
M) plus 10% selected FCS
from Hyclone Labs. (Logan, UT). Pigeon cytochrome c fragment
88-104 (PCCF), used as antigen in all experiments, was synthe-
sized by the Peptide Synthesis Facility (University of California,
San Diego, La Jolla, CA) and purified by HPLC. Con A was from
ICN ImmunoBiologicals (Lisle, IL). Recombinant IL-2 (human,
10–20 U/ml, from the Biological Response Modifiers Program,
National Institutes of Health, Bethesda, MD) or an equivalent dose
of murine IL-2 derived from the X63–IL-2 line transfected with
the murine IL-2 gene were used interchangeably and had equiva-
lent effects. Anti-Fas antibody (Jo2) or control antibody (hamster
IgG) (both from PharMingen, La Jolla, CA) and fluorescein (FL)-
conjugated goat anti–hamster IgG (Fab
 
9
 
)2 fraction (CALTAG,
South San Francisco, CA) were used to detect Fas expression on
the cell surface. Fas.Fc, a fusion protein of murine Fas and the Fc
region of human IgG (23), was used to block the FasL/Fas-medi-
ated interaction. Human IgG was used as a control in experi-
ments using Fas.Fc. The vital fluorescent dyes 5- (and 6-) carboxy-
fluorescein diacetate succinimidyl ester (CFSE; Molecular Probes
Inc., Eugene, OR; reference 29) and PKH26 (Sigma Chemical
Co., St. Louis, MO) were used to stain and visualize effector
populations which were then detected by FACScan
 
Ò
 
 analysis
(Becton Dickinson, San Jose, CA).
 
Cell Preparations.
 
Purified naive CD4
 
1
 
 T cells from Tg mice
or from C3H, 
 
lpr
 
, or 
 
gld
 
 mice were isolated as described previ-
ously (17). In brief, spleen cells were passed over nylon columns
to remove B cells, adherent cells, and activated cells. Populations
were then treated with anti-CD8 and anti-HSA (J11D) plus com-
plement (C
 
9
 
). The purified cell populations obtained were 
 
.
 
90%
CD4
 
1
 
 resting cells of naive phenotype. APC for effector genera-
tion were prepared by T cell depletion of spleen cells with two
anti-Thy1.2 Ab (F7D5 and HO13.14), anti-CD4 (RL172.4), and
anti-CD8 (HO2.2 and AD4) plus C
 
9
 
 and treatment with 50 
 
m
 
g/ml
of mitomycin C. For restimulation of effectors, DCEK-ICAM
(intracellular adhesion molecule) cells, a fibroblast line transfected
with I-E
 
k
 
 and ICAM-1 that also expresses high levels of B7.1
(10), were mitomycin C–treated and used as APC.
CD4 effectors were generated as previously reported (15, 18).
Purified naive CD4
 
1
 
 cells (3 
 
3
 
 10
 
5
 
/ml) from Tg mice were cul-
tured with PCCF and APC, whereas CD4
 
1
 
 cells from non-Tg mice
were stimulated with Con A (2 
 
m
 
g/ml) with APC. IL-2 and ei-
ther IL-12 and anti-IL-4 (11B11, 10 
 
m
 
g/ml) for polarization to
Th1 effectors, or IL-4 and anti-IFN-
 
g
 
 (XMG1.2, 10 
 
m
 
g/ml) for
Th2 effectors, were added at the initiation of culture to achieve
optimal growth and complete polarization (18). After 5 d, Th1
and Th2 effectors were harvested, and in some cases, low density
cells were enriched by Percoll gradient separation. Effectors were
restimulated at 5 
 
3
 
 10
 
5
 
/ml with PCCF (5 
 
m
 
M) and APC (1.7 
 
3
 
10
 
5
 
/ml) (transgenics), or with Con A (2 
 
m
 
g/ml) and APC. Ac-
cording to the design of the experiment, recultured effector cells
were harvested at different days, counted, and further analyzed
for evidence of DNA damage or ability to be stimulated to pro-
duce cytokines.
 
Cytokine Analysis.
 
Titers of IL-2, IL-4, IL-5, and IFN-
 
g
 
were determined from supernatants collected 18–24 h after re-
stimulation of T cells as described previously (18, 28). In brief,
IL-2 was measured by bioassay with the NK cell line. IL-4, IL-5,
and IFN-
 
g
 
 levels were determined by an ELISA assay.
 
Labeling of Effector Cells with Fluorescent Dyes.
 
Th1 effectors were
labeled with the vital dye CFSE as previously described (29). In
brief, 5 
 
3
 
 10
 
7
 
 Th1 effectors in 1 ml PBS were incubated with 1
mM CFSE at 37
 
8
 
C for 10 min. 10 ml of cold PBS was added to
stop the reaction. Labeled cells were washed once and counted.
Th2 effectors were labeled with PKH26. 2 
 
3
 
 10
 
7
 
 Th2 effectors in
1 ml of diluent were incubated with 1 ml of 4 
 
3
 
 10
 
6
 
 M PKH26
at 25
 
8
 
C for 2–5 min. 2 ml of serum was then added for 1 min to
stop the staining reaction, followed by addition of 4 ml of medium.
Labeled cells were washed three times and counted. Control ex-
periments indicated effectors, and naive T cells stained with both
dyes retained high and equal viability (Zhang, X., unpublished
data). Labeled effector cells (Th1, Th2, or 1:1 mix) were then
plated at 5 
 
3
 
 10
 
5
 
/culture and restimulated as in other experi-
ments. After 1 d, the entire culture was harvested, cell viability
and recovery was determined, and the whole culture was sub-
jected to FACS
 
Ò
 
 analysis. In some experiments, parallel cultures
were restimulated with PCCF and APC, and supernatants were
collected 24 h later for determination of cytokine titers.
 
TUNEL Staining for Detection of Nicked DNA.
 
DNA damage
was determined using a method adapted from Gorczyca et al. as
described (30). Effectors were harvested at different times after re- 
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stimulation, stained with rat anti–murine CD4 conjugated with
PE (PE–anti-CD4), fixed in 1% formaldehyde, and then stored in
70% ethanol at 0–4
 
8
 
C. For analysis, cells were incubated at 10
 
6
 
 in
50 ml of buffer containing 100 U/ml terminal deoxynucleotidyl
transferase (TdT) and 10 mM biotin-16-dUTP (both from Boeh-
ringer Mannheim, Indianapolis, IN) followed by FL-streptavidin
staining. Gated CD4
 
1
 
 cells were analyzed by FACScan
 
Ò
 
 using
Lysys II software. In some experiments, as indicated, only live CD4
 
1
 
cells with high forward and low side scatter were analyzed.
 
Fas and FasL Detection.
 
Fas expression was assessed by stain-
ing. Effector cells (10
 
6
 
) were incubated with either anti-Fas anti-
body (Jo2, PharMingen) or control antibody (hamster IgG), and
then counterstained with FL goat anti–hamster IgG (Fab
 
9
 
)
 
2
 
 frac-
tion. Cells were washed again and stained with PE–anti-CD4.
Gated CD4
 
1
 
 cells were analyzed for Fas expression by FACS-
can
 
Ò
 
. For detection of cell surface expression of FasL, cells were
stained with a direct PE-conjugated anti-FasL Ab (Kay-10; pro-
vided by PharMingen). As a control, cells were stained with a
PE-conjugated, isotype-matched Ab not expected to specifically
stain CD4 T cells (PE-conjugated anti–human CD8, Sigma Chem-
ical Co.). Cells were counterstained as above with FL anti-CD4.
Functional FasL expression was quantitated in a cytotoxicity assay
by determining the ability of effector cells to cause DNA frag-
mentation in Fas-expressing target cells. The parental L1210 cells
(Fas
 
2
 
) or the cells transfected with murine Fas (Fas
 
1
 
), gifts of
Pierre Golstein (Institut National de la Santè et de la Recherche
Mèdicale, Marseille, France), were labeled with 5 
 
m
 
Ci [
 
3
 
H]thy-
midine at 10
 
6
 
/ml for at least 2 h at 37
 
8
 
C and used as target cells.
Target cells at 2 
 
3
 
 10
 
4
 
 in 100 
 
m
 
l were cultured with 100 
 
m
 
l of
appropriately diluted effector cells in each well of flat-bottom 96-
well plates with either coated anti-CD3 (2 
 
m
 
g/ml, overnight) or
PCCF plus APC as stimuli. A1.1 cells, activated by anti-CD3,
were used as a positive control (23). The plates were harvested
using a Skatron cell harvester after 9 h incubation at 37
 
8
 
C and
[
 
3
 
H]thymidine-labeled unfragmented DNA was counted in a liq-
uid scintillation counter. The percentage of DNA fragmentation
was calculated with formula: % DNA fragmentation 
 
5
 
 100 
 
3
 
 (1 
 
2
 
cpm experimental group/cpm control group). Assays were per-
formed in triplicate.
 
RNase Protection Assay for Fas, FasL, and Fas-associated Phos-
phatase 1 Messenger RNA.
 
RPA was performed using a com-
mercial RPA kit (Ambion Inc., Austin, TX) according to the
manufacturer’s protocol. In brief, Fas, FasL (provided by P. Gol-
stein, Institut National de la Santè et de la Recherche Mèdicale,
Marseille, France, and S. Nagata, Osaka Bioscience Institute, Os-
aka, Japan, respectively), murine Fas-associated phosphatase 1
(FAP-1) cDNA (31), and 
 
b
 
-actin cDNA (positive control), were
cloned using pBluescript II and [
 
32
 
P]UTP-labeled antisense ribo-
probes were generated. 10 
 
3
 
 10
 
6
 
 of Th1 and Th2 effectors were
stimulated with antigen/APC and total RNA was isolated after 0,
1, 3, 5, 8, and 24 h. 10 
 
m
 
g RNA of each sample was hybridized
with indicated radiolabeled antisense RNA transcripts, and then
digested with RNase A/T1. Samples were then separated by
urea/SDS-PAGE and gel was exposed to x-ray film.
 
Results
 
Th1, but not Th2, Effectors Undergo Rapid AICD.
 
Addi-
tion of cytokines to antigen-stimulated, naive CD4 T cells
cultured in vitro for just a few days will direct their differ-
entiation into highly polarized Th1 and Th2 effectors (15–17).
Because such effectors have not been subjected to selective
effects of long-term culture, they are likely to represent
physiologically polarized T cell effector subsets which arise
in primary immune responses. We directly compared the
AICD of Th1 and Th2 effectors generated from highly pu-
rified naive CD4 populations derived from AND TCR
transgenic mice which express TCR specific for PCCF,
presented by I-Ek (18). Effectors were harvested after 4–5 d
of response to antigen in vitro and were then restimulated
with peptide antigen, PCCF, and APC in vitro. As shown
in Fig. 1 a, many antigen-restimulated Th1 effectors dis-
played detectable DNA fragmentation after 3–5 h indica-
tive of commitment to apoptosis, and the great majority of
Th1 effectors were apoptotic by 8 h. In contrast, only low
levels of DNA strand breaks could be detected in the Th2
population throughout the first 24 h. Effector cells restimu-
lated with antigen typically showed two, clearly separate,
populations as assessed by FACSÒ analysis of forward versus
side scatter. Here we show the percentage of TdT1 (indi-
cating TdT had access to fragmented DNA) CD4 cells in
the high forward and low side scatter population, i.e., the
portion of the population that had not already died. Analy-
sis of the rate of apoptosis over a longer period indicated
that high levels of DNA fragmentation were seen at both 1
and 2 d after restimulation in Th1 effectors, while Th2 ef-
fectors showed little TUNEL staining throughout this time
period (Fig. 1 b). By 4 d, the population of cells remaining
in the Th1 group were less apoptotic, suggesting that selec-
tion for cells resistant to apoptosis had occurred. Indeed,
Th1 effector cultures showed a rebound in cell recovery af-
ter 4 d when they were given IL-2 (not shown). By 4 d,
the Th2 population was just beginning to show increased
DNA fragmentation (Fig. 1 b), and as seen in earlier studies
(13), substantial levels of Th2 apoptosis were seen by day 7
(not shown). The rapid death of Th1 without a corre-
sponding apoptosis among Th2 effectors resulted in a marked
difference in cell recovery with Th1 effectors showing very
low recoveries after 1–4 d in the range of 40–60%, whereas
Th2 effectors increased over sixfold (Fig. 1 c). The increase
in Th2 number reflects their proliferation in response to re-
stimulation (13). Th1 effectors also begin to synthesize DNA.
Even at day 1, when most of Th1 effectors stained in the
TUNEL assay (Fig. 1, a and b) and showed other signs of
impending death such as shifts in forward versus side scatter
and incorporation of propidium iodide (not shown), the
incorporation of 3H[TdR] was nearly equivalent. (In a rep-
resentative experiment, Th1 incorporation 1 d after stimu-
lation and a 6-h labeling was a mean of 70,420 cpm against
a background of 743 cpm, while Th2 incorporated 172,543
cpm over a background of 2127 cpm). As expected, the Th1
incorporation of radiolabeled nucleotides decreases with
time as the majority of cells undergo apoptosis. The starting
Th1 and Th2 effector populations were highly polarized
with regard to their abilities to produce cytokines as illus-
trated in Fig. 1 d. Similar results have been obtained in all
polarized Th1 and Th2 effector experiments.
An earlier report indicated that Th2 lines would undergo1840 Th2 Effector Resistance to Apoptosis
as much apoptosis as Th1 lines when high doses of antigen
were used to stimulate activated T cells (32). To investigate
whether the difference between Th1 and Th2 effectors was
dependent on antigen dose, we examined the effect of pep-
tide dose on the AICD of Th1 and Th2 effectors after 1 and
2 d of culture (Fig. 2). In this experiment, because of the
many cultures that were harvested simultaneously, healthy
blasts were not isolated by lympholyte separation as in most
other experiments, and therefore the background of death
in the Th2 population was significantly higher, indicating
some cells had become committed to die during the initial
culture period. Both Th1 and Th2 effectors showed in-
creased AICD with high dose of antigen on day 1, but the
percentage of apoptotic cells was much higher in the Th1
than Th2 effectors at each dose. By day 2, there was sub-
stantial AICD in Th1 effectors, even in the absence of ad-
ditional antigen (0 mM PCCF). The kinetics of cell death
in the absence of antigen restimulation is shown below in
more detail. High doses of antigen increased AICD only
slightly after 2 d of restimulation of Th1 effector cultures,
but Th2 effectors were resistant to AICD at all concentra-
tions of peptide. Thus, Th1 effectors were much more sen-
sitive to AICD than Th2 effectors over a broad range of
antigen concentrations.
Th1, but Not Th2, Effectors Are Also Susceptible to Early
Programmed Cell Death. We next examined the kinetics of
Th1 and Th2 apoptosis in the absence (APC only) com-
pared to the presence (APC plus PCCF) of restimulation
with antigen. Stimulation of Th2 effectors with optimal pep-
tide concentration induced apoptosis 1–2 d sooner than cul-
ture without antigen, and a similar pattern was seen within
the Th1 population (Fig. 3). However, as before, the onset
Figure 1. Kinetics of AICD of
Th1 and Th2 effectors restimu-
lated with antigen. Effectors spe-
cific for PCCF were generated
in vitro from naive CD41 cells
of H-2k/k AND TCR Tg mice
(Vb3/Va11; see Materials and
Methods) After 5 d, Th1 and
Th2 effectors were harvested,
and low density cells obtained by
Percoll gradient separation were
restimulated at 5 3 105/ml with
PCCF (5 mM) and APC (1.7 3
105/ml). (a) Kinetics of Th1 and
Th2 AICD. Effector cells restim-
ulated for different times as
above were stained with TdT
and dUTP for detection of
nicked DNA (TUNEL method),
followed by biotinylated UTP,
and then FITC-streptavidin.
Gated CD41 cells were analyzed
for DNA strand breaks (TdT1
cells) by FACScanÒ analysis. The
results are the representative of
six experiments. (b) Longterm
kinetics of AICD. Effectors were
harvested at 1, 2, 3, and 4 d after
restimulation, and apoptosis in
live cells determined by TdT
staining as described above. (c) Kinetics of cell recovery. The cultures harvested in Fig. 1 b were also analyzed for number of viable effector cells deter-
mined counting trypan blue excluding cells. Results are expressed as the ratio of viable CD4 T cells recovered per culture per CD4 T cells plated at time
of restimulation. (d) Effector polarization. Cytokines were measured in the supernatants collected 18–24 h after restimulation of effector cells generated
from Tg mice. IL-2 titers (filled bar) were determined by bioassay. IFN-g, IL-4, and IL-5 titers were determined by ELISA as described in Materials and
Methods.
Figure 2. Effect of antigen dose on Th1 and Th2 AICD. Th1 or Th2
effector cells (5 3 105) and 1.7 3 105 DCEK APC were incubated in 1 ml
of medium and restimulated with graded concentrations of PCCF. After 1
and 2 d, cells were harvested from each culture and stained with TdT and
PE-CD4. The percentage of TdT1 CD41 T cells was determined as
above. Results are representative of three experiments.1841 Zhang et al.
of apoptosis in Th1 effectors occurred more quickly than in
Th2 effectors, where it was delayed several days. Thus, Th1
effector cells undergo more rapid death, both in the absence
(programmed cell death) and presence of antigen (AICD),
and stimulation by antigen induces apoptosis to occur more
rapidly in both Th populations.
Preferential Th2 Effector Survival Is an Intrinsic Property of
Th2 Effectors. Several mechanisms could be suggested to
account for this preferential death of Th1 effectors. Th1 ef-
fectors might preferentially express a cell surface receptor
such as Fas, which when engaged by FasL, could induce
death. Conversely, Th2 effectors might produce a cyto-
kine(s) which protects effectors from death. Alternatively,
there could be an intrinsic difference in susceptibility of the
cells to death, such as expression within the cell of compo-
nents that either promote or block pathways leading to ap-
optosis. In support of the first two possible mechanisms, it
has been reported that a Th1 clone could induce apoptosis
of a Th2 clone when Th1 and Th2 clones were mixed (8),
and we and others reported that some cytokines such as IL-2
and TGF-b (13) and IL-10 (33) can protect T cells from
AICD.
To explore the mechanisms responsible for unequal sus-
ceptibility of Th1 and Th2 effectors to cell death, we la-
beled Th1 and Th2 effectors with CFSE and PKH26, re-
spectively. These vital dyes fluoresce strongly with green
and red emissions, respectively, and are well retained by
live cells for extended periods of time (29) and through
several cell divisions. The stained cells can be directly de-
tected by flow cytometry (see Fig. 4, Day 0). As shown in
Fig. 4 (Day 0), Th1 and Th2 effectors were labeled and
then cultured separately (top and middle), or together in
equal numbers (bottom), either with APC alone or antigen
plus APC.
Figure 4. Differential survival of Th1 and Th2 in mixed culture. Th1 effector cells were labeled with CFSE (Green) and Th2 were labeled with
PKH26 (Red) using conditions designed to retain full cell viability. Aliquots of labeled Th1, Th2, and a 50:50 mix of the two were analyzed for red and
green fluorescence (left) and cell viability as determined by forward and side scatter (middle; Day 0). The three populations were then cultured at 5 3 105
in 1 ml of medium with 1.7 3 105 of APC in the presence of PCCF for 1 d. After 1 d, supernatants were removed and each culture was harvested and
counted. An aliquot was analyzed for red and green fluorescence (Day 1). Cell recovery per culture, based on the recovered cells numbers, was deter-
mined by trypan blue exclusion and is indicated below each day 1 fluorescence plot. The percentage of gated, dye-labeled cells not undergoing apoptosis,
as determined by forward versus side scatter, is indicated within the cell viability plot (middle). Cytokine titers were measured as in Fig. 1 d in the super-
natants (right).
Figure 3. Th1 effectors un-
dergo more rapid apoptosis with
and without restimulation. Th1
and Th2 effector cells at 5 3 105
per culture were stimulated with
1.7 3 105 of APC in 1 ml of me-
dium with or without PCCF (5
mM) for 1, 2, 4 and 7 d. At each
time, cultures were harvested
and stained with TdT and CD4
as above. The appearance of
TdT1 CD4 cells in Th1 (trian-
gles) and Th2 (circles) effector cul-
tures stimulated with antigen and
APC (closed) or with APC with-
out antigen (open) was deter-
mined. The results are the repre-
sentative of three experiments.1842 Th2 Effector Resistance to Apoptosis
After 1 d, whole cultures were harvested, viability and
cell recovery were determined, and recovery of labeled
cells was determined by flow cytometry (Fig. 4, Day 1). As
expected, the number of cells in the Th1 effector popula-
tion decreased (to 31% of initial recovery) when they were
cultured separately with peptide, whereas the Th2 popula-
tion remained at levels near those originally plated (118%
recovery). Mixed cultures had intermediate total cell re-
coveries (73.6%). A similar pattern was seen in the analysis
of cell viability of gated, dye-labeled cells by forward versus
side scatter depicted in Fig. 4 (middle, Cell Viability). In
Th2 cultures, viability of CD4 cells was 63%, whereas the
viability in the Th1 cultures was only 20%. When equal
numbers of Th1 and Th2 effectors were mixed with APC
in the presence of antigen, the percentage of Th1 effectors
decreased from an initial representation of 50.3 to 21.8%,
whereas that of the Th2 increased from 48.7% to 77.0%,
changing the ratio of Th2 to Th1 effectors from 1.00 at day
0 to 3.50 at day 2. Mixed cultures also had an intermediate
viability (34%). If effectors were cultured with APC with-
out antigen, there was little difference in the ratio of Th1
versus Th2 after 24 h, although the Th2 cells came to dom-
inate culture after 2–3 d (not shown). To substantiate the
functional significance of the apparent selective Th2 sur-
vival, initial populations (Th1 alone, Th2 alone and mixed,
plus the mix after 1 d) were restimulated with PCCF plus
APC, and supernatants were collected after 24 h and as-
sayed for cytokines. Results shown in Fig. 4 (right) show
that while the mixed cultures initially made both Th1 and
Th2 cytokines, after restimulation for 2 d only, Th2 cyto-
kines were still made in substantial amounts. Thus, Th1
and Th2 effectors underwent AICD at their own rate re-
gardless of whether they were in separate or in mixed cul-
tures. This suggests that Th1 effectors do not kill bystander
Th2 effector cells (fratricide) and that cytokines released by
stimulated Th2 effectors do not rescue Th1 effectors within
the time frame of these experiments. Similar results were
seen in two repeat experiments.
Development of the Susceptibility to AICD Occurs with the
Same Time Course as Generation of Effectors. To further evalu-
ate the unequal acquisition of susceptibility to AICD, we
cultured naive CD41 T cells with antigen plus APC in our
standard conditions for generating Th1 and Th2 effectors.
Our previous studies had suggested that acquisition of CD4
effector behavior, as determined by the levels of cytokines
produced upon restimulation and other phenotypic and
functional properties, showed a lag phase of 2–3 d, and
then rose sharply both in vitro (34) and in vivo (28). We
stimulated naive CD4 T cells under polarizing conditions
and removed aliquots at different times during the genera-
tion of effectors. Harvested cells were restimulated with an-
tigen and APC. The level of AICD was determined and
the cytokines in the supernatants were tested to monitor
whether the Th were capable of cytokine production (Fig.
5). Naive cells (day 0) were highly resistant to AICD and
produced only low levels of IL-2, with no detectable IL-4,
IL-5, or IFN-g, as detailed in previous studies (16; day 0
not shown). Analysis by restimulation 2 d after initiation of
effector generation cultures indicated that cells from both
cultures displayed the phenotype of activated T cells with
high CD44, lower L-selectin, high CD45RB, and high IL-2
receptor (not shown). However, after 2 d (Fig. 5, day 2),
both groups of cells produced only low titers of cytokines
upon restimulation, indicating that T cells were not yet
fully differentiated into effectors. Also after 2 d, both popu-
lations showed similar and low AICD. After 4 d of in vitro
differentiation, both Th1 and Th2 cultures secreted large
amount of cytokines after restimulation (Fig. 5, right, indi-
vidual cytokines produced) and the effectors were highly
polarized into Th1 or Th2 patterns. By 4 d, they also ex-
hibited unequal susceptibility to AICD. A majority of Th1
effectors (66–92%) were committed to apoptosis after anti-
Figure 5. Onset of AICD susceptibil-
ity and effector function. Naive CD41
cells (3 3 105/ml) from Tg mice were
cultured with PCCF/APC plus IL-2
(20 U/ml) and either IL-12 and anti-
IL-4 (11B11, 10 mg/ml) to induce po-
larization to Th1 effector (d), or IL-4
and anti-IFN-g (XMG1.2, 10 mg/ml)
to induce polarized Th2 effectors (m).
After 2, 4, and 6 d of differentiation in
vitro, effectors were harvested from Th1
and Th2 conditions. (a) Kinetics of de-
velopment of AICD. Cells were har-
vested from effector generation cultures
at different times and restimulated with
PCCF/APC for 1 d. Apoptosis was de-
termined by TdT staining. (b) Cytokine
production. Cells were harvested from
effector generation cultures at different
times and restimulated with PCCF/
APC. Supernatants were removed after
18–24 h, and cytokine titers were deter-
mined.1843 Zhang et al.
gen stimulation, whereas only z20% of Th2 effector un-
derwent AICD (Fig. 5, right). By day 6, cytokine produc-
tion was at its highest per given number of cells stimulated,
and the differences in AICD persisted. Thus, even though
cytokine production per se does not seem to be responsible
for the unequal susceptibility to AICD as indicated by the
mix experiment in Fig. 4, there is kinetic correlation be-
tween the onset of Th1 effector function and development
of susceptibility to AICD.
The Rapid AICD of Th1 Effectors Is Mediated by Fas/FasL
Pathway. To investigate whether effector cell death was
mediated by a Fas/FasL interaction, we used polyclonal
stimulation to generate Th1 and Th2 effectors from mice
with mutations in Fas (lpr) and FasL (gld), and compared
them to effectors from wild-type C3H mice. We used the
polyclonal mitogen Con A plus APC to stimulate effector
generation (9), since the donors were not TCR Tgs. The
Th1 and Th2 effectors generated were as well polarized as
antigen-generated Th1 and Th2 effectors, as indicated in
Fig. 6 a, which shows the cytokines produced by the polar-
ized effectors generated from C3H.lpr mice. Effectors gen-
erated from wild-type and C3H.gld mice were equally po-
larized (not shown). Differences in AICD were especially
marked at early time points (Fig. 6 b). Th1 effectors derived
from wild-type C3H mice underwent rapid apoptosis after re-
stimulation, as indicated by dramatic increases in TUNEL
staining from 0–24 h (Fig. 6 b), whereas TUNEL staining
in Th2 populations was very low during this time (see Fig.
6 d). In contrast, Th1 effectors derived from either the Fas
(lpr) or FasL (gld) mutant strains underwent little apoptosis
(Fig. 6 b). The lack of apoptosis in the Fas– and FasL–defi-
cient effectors was reflected in a sizable increase in cell re-
covery of about fourfold over the 2-d period, during which
time wild-type effectors were recovered in reduced num-
bers (not shown). By 4–6 d, mutant-derived Th1 effectors
began to exhibit DNA fragmentation with substantial num-
bers of apoptotic cells evident by day 7 (Fig. 6 c). Thus, a
second non-Fas/FasL pathway of cell death was operating
after several days. Wild-type Th2 effector populations ex-
hibited a delayed death (Fig. 6 d) resembling the non–Fas-
mediated Th1 death. Th2 effectors derived from lpr and gld
animals were only slightly resistant to this second phase of
apoptosis. Thus, a second phase of Fas-independent apop-
tosis was evident in both Th1 and Th2 effector popula-
tions. Therefore, the rapid AICD that Th1, but not Th2,
effectors undergo is mediated, at least in large part, by a
Fas/FasL interaction, while a slower, Fas-independent mecha-
nism is responsible for delayed AICD and is present in both
subsets.
Further Evidence for the Role of Fas/FasL in Activation-induced
Th1 Apoptosis. To substantiate the role of Fas in Th1, but
not Th2, effector death, Jo2 antibody to Fas was added to
both Th1 and Th2 effectors during a 2-d culture, with
hamster Ig as a control. Only Th1 effector death was influ-
enced, and it was blocked .50% by the addition of soluble
Ab at 10 mg/ml (not shown). To further explore the roles
of Fas, we also tested whether Fas.Fc would selectively
block activation-induced Th1 effector death. Th1 and Th2
effectors were generated from TCR Tg CD4 T cells as be-
fore, and effectors were restimulated for 2 d with PCCF
plus APC in the presence of various doses of a Fas.Fc fusion
protein or control human IgG. Results are shown in Fig. 7
a. The apoptosis of Th1 effectors was blocked substantially
by the soluble Fas construct. The minimal apoptosis of Th2
effectors was not exhibited by the Fas.Fc. Altogether, this
study provides compelling evidence that Th1 undergo a
rapid, Fas/FasL mediated apoptosis, but that Th2 effectors
are resistant to being killed by this mechanism.
Fas and FasL Expression of Th1 and Th2 Effectors Is Simi-
lar. An earlier study reported that Th1 cell lines express
Figure 6. Role of Fas and FasL in effector AICD. Th1 and Th2 effec-
tor cells were generated in vitro from naive CD41 cells obtained from
C3H (j), C3H.MRL-Faslpr (d), and C3H/HeJ-FasLgld (m) mice by cul-
ture with Con A (2 mg/ml) and DCEK-ICAM APC in the presence of
IL-2 plus either IL-12 and anti–IL-4 (11B11) or IL-4 and anti–IFN-g, re-
spectively. After 5 d, well-polarized Th1 or Th2 effectors (5 3 105/ml)
were recovered and stimulated with Con A (2 mg/ml) and APC (1.7 3
105/ml) again for hours or days as indicated. At the various times after re-
stimulation, cultures were harvested. Viability was determined and sam-
ples were stained with TdT as described above. (a) Cytokine polarization.
In parallel cultures, the effector populations were restimulated as above
and supernatants were harvested 18–24 h after restimulation for determi-
nation of cytokine titers. The cytokine pattern of Th1 and Th2 effectors
from wild-type C3H and C3H.lpr mice were very similar to those from
gld mice (not shown). IL-2 was tested by bioassay, and IFN-g, IL-4, and
IL-5 by ELISA. (b) Kinetics of Th1 AICD. Th1 effector cells from each
group were stained with PE–anti-CD4 and TdT/dUTP. The percentage
of TdT1 among gated CD4 effector cells harvested at 0, 5, 8, 24, and 48 h
from C3H (j), lpr (d), and gld (m) mice was determined. (c and d) Long-
term kinetics of AICD. The percentage of TdT1 gated CD4 cells in Th1
(c) and Th2 (d) effector mice were determined 1, 2, 4, and 7 d after re-
stimulation.1844 Th2 Effector Resistance to Apoptosis
somewhat higher levels of FasL than Th2 lines and sug-
gested that this may account for unequal susceptibility to
AICD of the two types of lines (8). However, there are also
examples in which both Fas and FasL are expressed by T cells,
but the T cells are not committed to death (31). Therefore,
we further examined the kinetics of expression of FasL and
Fas by Th1 and Th2 effectors before and after restimula-
tion. First, we used the anti-FasL antibody to visualize FasL
expression on effectors. The expression of FasL on effectors
(Fig. 7 b, 0 h) was not detectable, indicating either that ef-
fectors do not initially express FasL, or that expression is be-
low the limits of detection using this method. However, by
8 h after stimulation, expression of FasL was seen and was
equivalent on Th1 and Th2 effectors. By 24 h, levels of
FasL were again reduced to undetectable levels. A func-
tional analysis of FasL expression is shown below.
To further explore the expression of the components of
the Fas pathway, we stained effectors both immediately af-
ter generation and at several time points for expression of
Fas with the Jo2 Ab. As seen in Fig. 8 a, Th1 and Th2 ef-
fectors initially expressed equivalent low levels of cell sur-
face Fas at the time of harvest (0 h). Fas expression in-
creased in both populations 3 and 5 h after restimulation,
and then declined slightly by 8 h. Again, the levels of ex-
pression by Th1 and Th2 effectors were comparable.
Because the initial staining of Th1 and Th2 effectors be-
fore restimulation for FasL was too low to make a defini-
tive conclusion as to levels, we also assessed functional FasL
expression by measuring the abilities of Th1 and Th2 effec-
tors to kill Fas1 versus Fas2 targets (Fig. 8 b). Th1 and Th2
effectors were equivalent in their ability to induce apoptosis
in the Fas1 targets, whereas neither killed targets not ex-
pressing Fas, indicating similar functional expression of FasL
in both Th1 and Th2 effectors. Together, these experi-
ments emphasize that levels of expression of Fas or FasL is
unlikely to be the major factor responsible for the resistance
of Th2 effectors to AICD.
FAP-1 Is Expressed at Higher Levels in Th2 Effectors.
We therefore sought another explanation for this difference
in Th1 and Th2 susceptibility to apoptosis. Since Bcl-2 and
Bcl-xL function as important regulators of apoptosis (35),
we examined the expression of these two molecules on
Th1 and Th2 effectors. Th1 and Th2 effectors expressed
comparable Bcl-2 and Bcl-xL (not shown) before and after
antigen stimulation, which suggested that these two mole-
cules do not play an important role in the differential sus-
ceptibility of Th1 and Th2 effectors (Zhang, X., L. Tsui,
and S.L. Swain, unpublished data). A recent report indi-
cated that FAP-1 can block the Fas-mediated death signal-
ing cascade and protect some cells from AICD (31), so we
examined the expression of FAP-1 messenger RNA (mRNA)
by RNAse protection and also examined levels of Fas and
FasL mRNA expression (Fig. 8 c). mRNA levels for both
Fas and FasL were initially comparable in the RNA from
Th1 and Th2 effectors, consistent with the staining and
function studies above. Both Fas and FasL expression were
retained in the Th1 effectors over the next 24 h, whereas
expression of both RNAs were decreased in Th2 effectors
after stimulation. FasL mRNA remained high for at least
5–8 h in both populations, although FasL was downregulated
more rapidly in Th2, becoming barely detectable by 24 h
(Fig. 8 c). Moreover, since activation-induced, Fas/FasL-
mediated apoptosis occurs rapidly (within 12 h) in Th1 ef-
fectors, the small differences in expression of Fas and FasL
at later time points noted above could not be expected to
account for the difference in susceptibility to AICD.
We observed a dramatic difference between Th1 and
Th2 effectors in their expression of FAP-1 mRNA (Fig. 8 c)
that correlated inversely with apoptosis. Unstimulated Th2
effectors expressed easily detectable FAP-1 mRNA, whereas
Th1 effectors express very little. After restimulation, FAP-1
mRNA declined in Th1 effectors from very low levels to
undetectable levels, but remained at easily detectable levels
in Th2 effectors. By 24 h, FAP-1 levels in Th2 effectors
Figure 7. Role of FasL in Th1 death. Th1 and Th2 effectors were gen-
erated from AND mice as in previous experiments. (a) Inhibition of Th1
death by Fas.Fc. The ability of Fas.Fc to block the apoptosis of Th1 and
Th2 effectors was determined. Aliquots of 5 3 105/ml Th1 or Th2 effec-
tors were cultured with PCCF/APC and several concentrations of either
Fas.Fc fusion protein or the control human IgG. 2 d after restimulation,
cells in each culture were harvested and stained with TdT and PE–anti-
CD4 to analyze apoptosis. TdT1 cells from the CD41 population were
analyzed. (b) Kinetics of FasL expression. Cell surface expression of FasL
on Th1 and Th2 effector cells, restimulated with PCCF and APC for 0,
8, or 24 h, was assessed by staining. Effectors harvested at each time point
were stained with FITC–anti-CD4 and PE–anti-FasL (bold lines) or PE–
anti-CD8 (light lines) as control.1845 Zhang et al.
were high, while Fas and FasL were low. Thus, Th1 and
Th2 effectors show a marked difference in expression of
FAP-1, which could account for their differences in rapid
Fas-induced AICD both in the presence and absence of re-
stimulation with antigen. Similar results were seen in a re-
peat RPA assay.
Altogether, the results of cell surface expression of Fas
and FasL, mixtures of Th1 and Th2 effectors, functional ac-
tivity of FasL, and presence of RNA for Fas and FasL sug-
gest that although rapid AICD in Th1 cells is mediated by
the Fas/FasL pathway, the resistance of Th2 cells cannot be
simply explained by the absence or low levels of Fas or
FasL, and that some additional intrinsic difference is re-
sponsible for their failure to commit suicide. Since FAP-1
has been implicated in blocking the Fas/FasL mediated
death pathway, the observed difference in FAP-1 expres-
sion by Th2 cells is an obvious candidate for a difference
which might be partly or wholly responsible for the un-
equal death of the Th1 and Th2 effector populations.
Discussion
Our results identify a major functional difference be-
tween short-term, in vitro–cultured Th1 and Th2 effectors
which can lead to the preferential survival of Th2 effectors
and may be relevant to a number of in vivo disease states in
which Th2 dominance is seen. Our studies clearly show
that short-term, polarized effector T cells differ dramatically
in their susceptibility to apoptosis. Thus, while Th1 effec-
tors undergo rapid Fas/FasL-mediated AICD 5–12 h after
restimulation and also die within 2 d without restimulation,
Th2 effectors escape this fate despite expression of both Fas
and FasL, remaining resistant to death for 4–7 d in the pres-
ence or absence of antigen. Both types of effectors are sus-
ceptible to delayed, non–Fas-mediated death. This unequal
susceptibility to death is apparently an intrinsic property of
the subsets, since there is also selective loss of the Th1 pop-
ulation in mixed cultures of Th1 and Th2 effectors. The
susceptibility to rapid Fas/FasL-mediated apoptosis devel-
Figure 8. Fas, FasL, and FAP-1 expression in Th1 and Th2 effectors.
Th1 and Th2 effectors were generated from naive CD4 cells from AND
mice as before, and aliquots were restimulated with PCCF and APC in
vitro. Cells were collected at different time points after restimulation. (a)
Fas expression by effectors. Th1 and Th2 effector cells restimulated for 0,
3, 5, or 8 h were stained with either hamster anti–mouse Fas antibody
(Jo2, shaded peaks) or hamster IgG (open peaks), followed by FL-conju-
gated goat anti–hamster IgG (Fab9)2 fraction. Cells were counterstained
with PE–anti-CD4. Gated CD41 cells were analyzed for Fas expression
by FACScanÒ, using Lysys II software. (b) Fas-mediated killing by effectors.
Functional FasL expression was determined by assessing the ability of Th1
and Th2 effector cells (not restimulated) to cause DNA fragmentation in
Fas1 target cells as described in Materials and Methods. Parental L1210
cells (Fas2, s or h) or the same line transfected with murine Fas (Fas1, d
or j) were labeled with 5 mCi [3H]thymidine and used as target cells. 2 3
104/100 ml targets were cultured with 100 ml of appropriately diluted
Th1 (s, d) or Th2 (h, j) effector cells stimulated with anti-CD3. A1.1
cells, activated by anti-CD3, were used as positive control. The percent-
age of DNA fragmentation was calculated from thymidine counting with
formula. Assays were performed in triplicate and means are shown. (c) Ex-
pression of Fas, FasL, and FAP-1 mRNA. RNA was isolated from effec-
tors restimulated with PCCF/APC for 0, 1, 3, 5, 8, and 24 h. An RPA
was run on the isolated RNA using a commercial RPA kit (Ambion Inc.)
according to the manufacturer’s protocol. Fas, FasL, murine FAP-1 cDNA,
and b-actin cDNA (positive control), were cloned using pBluescript II.
Total RNA was isolated from 10 3 106 Th1 and Th2 restimulated effec-
tors. 10 mg RNA from each sample was hybridized with indicated radio-
labeled antisense RNA transcripts, and then digested with RNase A/T1.
Samples were then separated by urea/SDS-PAGE and gel was exposed to
x-ray film. Results are representative of two similar experiments.1846 Th2 Effector Resistance to Apoptosis
ops as naive cells become Th1-polarized effectors. Interest-
ingly, Th2 effectors express higher FAP-1 mRNA, sug-
gesting that FAP-1 may act to prevent Fas/FasL-mediated
cell death in Th2 effectors both before and after antigen
stimulation. This provides the first instance where expres-
sion of FAP-1 in untransfected cells expressing Fas and FasL
is correlated with resistance to Fas-mediated apoptosis, and
provides a potential mechanism for inhibiting apoptosis.
The failure of several other groups to see differences sim-
ilar to those illustrated here between Th1 and Th2 effec-
tors, may be due to the use of effector populations that are
not as well polarized as the ones used in the studies re-
ported here (Figs. 1 and 6). We have optimized protocols
for achieving polarization, and have found that use of highly
purified naive cells from TCR Tg mice, which are uncon-
taminated by even low numbers of activated cells, and low
density cultures result in the most well-polarized popula-
tion. We have seen dramatic differences in AICD between
Th1 and Th2 effectors, such as those shown, in 14 out of 14
experiments. The susceptibility of CD4 cells to rapid AICD
develops only after .2 d of culture of naive cells under
Th1-polarizing conditions, as the cells with naive pheno-
type shift to expression of an effector phenotype character-
ized both by shifts in expression of cell surface markers and
by their capacity to secrete high titers of Th1 cytokines
upon restimulation (Fig. 5). We have also found that effec-
tors generated in IL-2 alone (without IL-12), which secrete
higher IL-2 and lower IFN-g than Th1, but no detectable
IL-4 and IL-5, also undergo similar rapid AICD as Th1 ef-
fectors (not shown), and thus suggest that the susceptibility
to AICD may be the default pattern and that only the most
well-polarized Th2 effectors are resistant.
Fas/FasL coexpression and interaction leading to apopto-
sis is one of the main pathways responsible for the AICD of
activated CD41 T cells (22–24, 36, 37). The rapid AICD
in Th1 effector cells is clearly mediated in large part by Fas/
FasL, since Th1 effectors from mice deficient either in Fas
(lpr) or in FasL (gld) are resistant to the rapid AICD (Fig. 6),
whereas the delayed death of Th1 and Th2 death are not
affected. Moreover, the rapid AICD of Th1 effectors is
largely blocked either by soluble Ab to Fas or by Fas.Fc fu-
sion protein in soluble form (Fig. 7). However, differences
in Fas and FasL expression on effectors do not appear to be
responsible for the dramatic differences between Th1 and
Th2 AICD seen in the first 24–48 h. Th1 and Th2 effectors
express equivalent levels of Fas (Fig. 8), both initially and
for the first 8 h, by which time the Th1, but not the Th2,
effectors exhibit striking DNA damage that presumably in-
dicates they are already committed to apoptosis. The ex-
pression of Fas is increased in Th effectors after stimulation
(Fig. 8), which could contribute to the faster rate of apop-
tosis in Th1 effectors after antigen stimulation. FasL expres-
sion is undetectable by Ab staining of either Th1 or Th2
effectors before restimulation, but increases to detectable
levels by 8 h (Fig. 7). However, functional FasL expression
is detectable since both effectors can mediate equivalent in-
duction of apoptosis in Fas1, but not Fas2, targets (Fig. 8 b).
The analysis of mRNA expression indicates that FasL ex-
pression may be selectively downregulated among Th2 ef-
fectors by 24 h, which could contribute to the continuing
resistance of Th2 effectors to apoptosis, but this difference
is insufficient to explain the large difference in DNA dam-
age and cell death during the first 12 h of culture after re-
stimulation. An earlier report indicated that FasL was ex-
pressed at higher levels on Th1 lines (8), and also found
short-term Th2 lines expressed substantially more FasL than
Th2 clones. Another study reported that Fas/FasL were ex-
pressed not only by activated Th1, but also by some Th2
clones (37). Thus, we conclude that the expression of Fas
and FasL is required for rapid effector death but not suffi-
cient for such death, and the differences in Fas or FasL ex-
pression are not likely to be primarily responsible for the
unequal death in the Th1 and Th2 effectors reported here.
FAP-1 can interact with the intracellular tail of Fas and
inhibit Fas signal transduction, according to experiments in
which FAP-1 expression is forced in Jurkat cells (31). The
correlation of FAP-1 mRNA expression with Th2 resis-
tance to apoptosis provides the first evidence that regula-
tion of FAP-1 expression may be an important mechanism
determining T effector fate. Our results indicate that the
expression of FAP-1 is inversely correlated with the differ-
ential AICD and programmed cell death of Th1 and Th2
effectors (Fig. 8 c), supporting a model in which FAP-1 ex-
pression is responsible for the resistance of AICD in Th2
cells. The fact that Th1 and Th2 effectors differ only in the
Fas/FasL-mediated rapid death pathway, but not in the
non–Fas-mediated slower death pathway is consistent with
a specific difference of the Fas-mediated pathway such as
would be seen with FAP-1. Further studies to determine
what induces FAP-1 expression and how closely it is corre-
lated with Th2 cytokine polarization and resistance to cell
death should shed further light on factors that are active in
conferring Th2 resistance to apoptosis.
The studies reported here support a model in which an in-
trinsic difference(s) between Th1 and Th2 subsets is respon-
sible for their unequal susceptibilities to Fas-mediated AICD.
Either mixed or cultured separately, Th1 and Th2 effectors
died at the same rate (Fig. 4) so that after 1 d, Th2 predom-
inate in mixed cultures, which also become unable to pro-
duce Th1 cytokines, IL-2, and IFN-g in significant amounts.
The Th1 plus Th2 effector mix experiments suggest that
Th1 effectors do not indiscriminately kill bystander Th2 ef-
fector cells, ruling out an indiscriminate fratricidal mecha-
nism, such as was suggested previously for Th1 cell lines
(8). Earlier studies had indicated that Fas/FasL interactions
could mediate cell death by a cell autonomous mechanism
(23, 37) and the rapid Th1 apoptosis seen here may depend
on such a mechanism. The mix experiments suggest that
production of and response to Th2 cytokines was not re-
sponsible for resistance of Th2 effectors to apoptosis. An
additional argument against a role for cytokines in deter-
mining the unequal death of Th1 and Th2 effectors are the
facts that cytokine production by effectors peaks only 6–12 h
after restimulation (8), whereas Th1 effectors have consid-1847 Zhang et al.
erable commitment to cell death even at 5 h, as indicated by
DNA fragmentation detected by TUNEL assay (Fig. 1). It
is also notable that even though the Th1 effectors are in the
midst of dying as just noted, they nonetheless produce and
secrete high levels of cytokines (Figs. 5 and 6) and incorpo-
rate radiolabeled nucleotides at high rates as if they were
going to divide. All indications are that the DNA breaks
detected by the TUNEL staining are well correlated with
true cell death and cell disappearance, since very low Th1
cell recovery follows Th1, but not Th2, restimulation (Fig. 1).
It is noteworthy that both Th1 and Th2 effectors which
are cultured without antigen die more slowly than when
they are restimulated; however, the Th1 effectors nonethe-
less undergo death much sooner than the Th2 effectors
(Fig. 3). One possible scenario is that in effectors that are
not restimulated, levels of FasL are sufficient only for occa-
sional induction of apoptosis (Fig. 7 b), and that restimula-
tion leads to rapid expression of FasL (probably from intra-
cellular stores), as well as higher Fas expression (Fig. 8 a)
allowing a high level of Fas/FasL interaction.
The unequal death of the two effector subsets might po-
tentially be due to any number of intrinsic differences be-
tween the subsets. Therefore, we searched for evidence
that the expression of other components in death pathways
were responsible. Several studies have suggested that the
presence of Bcl-2 on one hand (38, 39), or Bcl-xL(35) on
the other, can protect T cells from apoptosis. But others
have not found a role for Bcl-2 in blocking effector T cells
from AICD (40, 41). van Parijs et al. concluded that induc-
tion of Bcl-xL by costimulation could protect naive T cells
that die by a non–Fas-mediated pathway, but not activated
T cells that use a Fas/FasL mechanism (41). We find that
Bcl-2 and Bcl-xL expression is comparable in the Th1 and
Th2 effectors (Zhang, X., L. Tsui, and S.L. Swain, unpub-
lished data), implying that differential expression of these
proteins by Th2 and Th1 effectors is not likely to be re-
sponsible for the differences in cell death observed. Of
course other proteins which negatively regulate the Fas-
mediated death pathway might play a major or ancillary
role in protecting Th2 effectors.
We recently showed that the cytokines, IL-2, and TGF-
b1 were able to prevent Th2 effector death (13). We find
that restimulated Th1 effectors are also rescued in the pres-
ence of TGF-b1 (our manuscript in preparation), provid-
ing a potential mechanism for Th1 effector expansion and
suggesting that the effect of TGF-b is on a common apop-
tosis pathway shared by Fas– and non–Fas-mediated mech-
anisms of apoptosis. However, because the onset of death
of Th1 effectors is rapid (within a few hours), they will
have much less opportunity than their Th2 counterparts to
encounter cytokines or other agents which might interfere
with or block apoptosis and allow their expansion.
Differences in the susceptibility of Th1 and Th2 subsets
to AICD can be expected to have a major impact on the
course of immune responses. If in vivo Th1 effector popu-
lations that reencounter antigen rapidly produce cytokines
and then die, it would bring an end to the effector re-
sponse. The in vivo behavior of Th1 effectors in the pres-
ence or absence of restimulation with antigen has yet to be
clearly recorded, but some viral infections similarly pro-
duce such a rapid exhaustion of the effector response (42).
Based on our in vitro results, we predict that Th2 effectors
will also behave differently in vivo, which could result in a
shift in the response towards a more Th2 pattern with time
in vivo. It may be one of the mechanisms of rapid loss of
Th1, but not Th2, via Fas/FasL-mediated AICD in pro-
gressive HIV infection (3), and of selective loss of Th1 in
the tolerance induced in vivo by antigen without adjuvants
(4, 5). Clearly, further experiments will have to be done to
analyze whether such a mechanism of selective Th1 death
is responsible in vivo, but it is clearly an attractive possibil-
ity. Selective Th1 effector death in vitro may also partly ex-
plain the selective Th2 polarization which occurs when
high doses of antigen are used to stimulate naive cells to de-
velop into effectors (6; Rogers, P., X. Zhang, and S.L. Swain,
manuscript submitted).
Thus, the difference in rates of AICD represents a clear
distinction between Th1 and Th2 subsets, which provides
one of the clearest differences (other than cytokine produc-
tion) that differentiate between Th1 and Th2 effectors gen-
erated in short-term, in vitro cultures, and it provides a
new clue to potential mechanisms that could contribute to
the imbalance between Th subsets in many chronic diseases
where massive or repeated antigen exposure may deplete
Th1-polarized effectors leading to Th2 predominance.
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